ORG Partners’s Biogen BIIB Stock Holding History

ORG Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$10.2K	Buy	58 +15	+35%	+$2.45K	﹤0.01%	1005
2025 Q3	$6.02K	Buy	43 +20	+87%	+$2.7K	﹤0.01%	1089
2025 Q2	$2.99K	Buy	+23	New	+$2.87K	﹤0.01%	1149

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ORG Partners's BIIB Position: Q4 2025 in Review

ORG Partners increased its Biogen (BIIB) stake by 35% in Q4 2025, buying an estimated $2.45K and bringing the position to 58 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

ORG Partners first reported a position in BIIB in Q2 2025 and has held it in 3 quarters since. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

ORG Partners held 58 shares of Biogen worth $10.2K as of Q4 2025.
ORG Partners bought 15 Biogen shares in Q4 2025, an estimated $2.45K.
Biogen made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1005 holding.
ORG Partners first reported a position in Biogen in Q2 2025 and has held it in 3 quarters since.
997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.